Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6170
Understanding Osteoarthritis and The Role of Stem Cells - Cord Blood

Cord Blood

and Stem Cell Banking

Understanding Osteoarthritis and The Role of Stem Cells

Cell cross section

Osteoarthritis (OA) is a condition we all dread – well, who wants to struggle on those stairs or feel pain every time they get up from their comfy couch?

Stubborn and progressively worsening, osteoarthritis affects both small and large joints, leading to symptoms like knee pain, restricted movement, and inflammation. According to the stats, about 18% of women over 60 are battling with OA.

The good news? Science has our backs! Medical researchers have found that mesenchymal stem cells (MSCs) can play a significant role in the treatment of OA.

Decoding the Stem Cell Magic

So, where do stem cells come in? Well, stem cells are like the superheroes of regeneration. They can morph into (or “differentiate,” if we’re being scientifically accurate) various types of cells, like bone cells (osteoblasts), fat cells (adipocytes), and cartilage cells (chondrocytes), and therefore serve as potential treatment options.

These stem cells originate from sources like bone marrow (BM-MSCs), synovial fluid (SF-MSCs) in our joints, umbilical cord blood, and even our body fat. Nothing goes to waste in our bodies, literally!

Risks & Obstacles with Current Treatment Methods

However, like every other superhero movie, our story also has its villains. One of them being the shortcoming of current treatment options for OA. Typical treatments only manage the symptoms; they can’t reverse the condition. So while they might delay the progression, they don’t halt or undo the damage.

Worst case scenarios often require joint replacement and it can lead to complications like postoperative pain or a period of stiffness.

Exploring Stem Cell Therapy for Osteoarthritis

Stem cell therapy seems to hold the knight-in-shining-armor promise for osteoarthritis sufferers. Not only can MSCs replenish and differentiate into cartilage cells, but they also have unique immunological properties that boost their therapeutic effectiveness and safety.

Medical studies have found a high volume of SF-MSCs in the joint fluid of patients with OA. Unlike BM-MSCs, SF-MSCs can be obtained from medical waste like patients’ arthroscopic irrigation fluid. This means it’s relatively easier to harvest these cells, plus they can morph into cartilage more efficiently. These cells, when injected into joints, have demonstrated improvements in animals with OA or cartilage damage.

Risk Consideration with Stem Cell Therapy

The global medical-scientific community is actively promoting MSCs to serve patients better, but they’re also cautious about potential risks. Just like any treatment, biosafety must be prioritised, and the process shouldn’t involve multiple invasive procedures for the patients.